Introduction - Lipid Nanoparticles: Production, Characterization and Stability - page 9

Sznitowska M, Gajewska M, Janicki S, Radwanska A, Lukowski G (2001) Bioavailability of
diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles
after rectal administration in rabbits. Eur J Pharm Biopharm 52(2):159-163
Sznitowska M, Janicki S, Gajewska M, Kulik M (2000) Investigation of diazepam lipospheres
based on Witepsol and lecithin intended for oral or rectal delivery. Acta Pol Pharm 57:61-64
Videira M, Botelho M, Santos A, Gouveia L, de Lima J, Almeida A (2002) Lymphatic uptake of
pulmonary delivered radiolabelled solid lipid nanoparticles. J Drug Target 10(8):607-613
Waitzberg D, Torrinhas R, Jacintho T (2006) New parenteral lipid emulsions for clinical use.
JPen-Parenter Enter 30(4):351-367
Washington C (1996) Stability of lipid emulsions for drug delivery. Adv Drug Deliver Rev
20(2-3):131-145
Westesen K (2000) Novel lipid-based colloidal dispersions as potential drug administration sys-
tems—expectations and reality. Colloid Polym Sci 278:608-619
Wissing S, Kayser O, Müller R (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv
Drug Deliver Rev 56(9):1257-1272
Wong H, Bendayan R, Rauth A, Wu X (2004) Development of solid lipid nanoparticles con-
taining ionically complexed chemotherapeutic drugs and chemosensitizers. J Pharm Sci
93(8):1993-2008
Wong H, Bendayan R, Rauth A, Wu X (2006a) Simultaneous delivery of doxorubicin and GG918
(Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of mul-
tidrug-resistant breast cancer. J Control Release 116(3):275-284
Wong H, Bendayan R, Rauth A, Xue H, Babakhanian K, Wu X (2006b) A mechanistic study of
enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a
polymer-lipid hybrid nanoparticle (PLN) system. J Pharmacol Exp Ther 317:1372-1381
Wong H, Rauth A, Bendayan R, Manias J, Ramaswamy M, Liu Z et al (2006c) A new polymer-
lipid hybrid nanoparticle system increases cytotoxicity of Doxorubicin against multidrug-
resistant human breast cancer cells Pharm Res. 23(7):1574-1585
Wong H, Rauth A, Bendayan R, Wu X (2007) In vivo evaluation of a new polymer-lipid hybrid
nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. Eur J Pharm
Biopharm 65(3):300-308
Yang S, Lu L, Cai Y, Zhu J, Liang B, Yang C (1999) Body distribution in mice of intravenously
injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control
Release 59(3):299-307